# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001213900-15-005856
Filing Date
2015-08-10
Accepted
2015-08-10 08:05:28
Documents
5
Period of Report
2015-08-04
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | CURRENT REPORT | f8k080415_relmadatherape.htm | 8-K | 43977
2 | CERTIFICATE OF CHANGE OF RELMADA THERAPEUTICS DATED AUGUST 4, 2015 | f8k080415ex3i_relmada.htm | EX-3.1 | 552
3 | PRESS RELEASE OF RELMADA THERAPEUTICS, INC., DATED AUGUST 10, 2015 | f8k080415ex99i_relmada.htm | EX-99.1 | 13606
4 | GRAPHIC | img001_ex99i.jpg | GRAPHIC | 9113
5 | GRAPHIC | ex3i.jpg | GRAPHIC | 604257
| Complete submission text file | 0001213900-15-005856.txt |  | 904419

Mailing Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-702-7163
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-55347 | Film No.: 151039235
SIC: 2834 Pharmaceutical Preparations